Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 56%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare's positive outlook is supported by its strategic investments in the USPI segment, which is characterized by faster growth, higher margins, and superior returns. Projections indicate that revenue from equity earnings is expected to rise in 2026 compared to 2025, demonstrating the company's financial growth potential. Furthermore, factors such as strong demand, an improved payer mix, diminishing operational pressures, and the transformation within the USPI segment collectively enhance the visibility of margin expansion across the organization.

Bears say

The analysis highlights concerns regarding Tenet Healthcare's impending financial challenges due to the anticipated expiration of subsidies, which may result in a significant loss of coverage for 80-85% of its patient population, thereby leading to a projected decline in utilization. The potential $220 million headwind to the Acute segment and a $30 million headwind to USPI emphasizes the substantial risks that could adversely affect revenue growth in 2026. Furthermore, despite a recent infusion of $148 million from non-recurring Medicaid state funds, this temporary boost raises skepticism about the sustainability of Tenet's financial performance amidst these mounting pressures.

Tenet Healthcare (THC) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 56% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 18 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.28, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.28, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.